Published in Pharma Investments, Ventures and Law Weekly, November 6th, 2005
The company previously announced that it received notices of potential delisting due to the failure to timely file its fiscal 2004 Annual Report on Form 10-K (the 2004 Form 10-K) and its Quarterly Reports on Form 10-Q for the first and second fiscal quarters of 2005 (collectively, the "First and Second Quarter 10-Qs").
The company filed the 2004...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly